MORGAN STANLEY - 31 Dec 2025 SCHEDULE 13G/A Report for Arbutus Biopharma Corp Common Shares (ABUS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Arbutus Biopharma Corp Common Shares
Symbol
ABUS
Shares outstanding
191,928,422 shares
Disclosed Ownership
25,910,337 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2026, 13:45:46 UTC
Date of event
31 Dec 2025
Previous filing
03 Feb 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 14% 25,910,337 0 25,899,506 Chris O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Investment Management Inc. 13% 25,647,127 0 25,647,127 Deidre A. Downes Authorized Signatory, Morgan Stanley Investment Management Inc.